Influence of two different e.coli asparaginase preparations on coagulation and fibrinolysis: A randomized trial
Authors:
- 1 January 1994
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 8, 66-68
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Enhanced thrombin generation, P-von willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: Predictive for venous thrombosis in asparaginase-treated childrenFibrinolysis, 1994
- Univariate Tolerance Regions for Fibrinogen, Antithrombin III, Protein C, Protein S, Plasminogen and α2-Antiplasmin in Children Using the New Automated Coagulation Laboratory (ACL) MethodKlinische Padiatrie, 1994
- Nomenclature of Quantities and Units in Thrombosis and Haemostasis (Recommendation 1993)Thrombosis and Haemostasis, 1994
- Unbalanced Coagulation-Fibrinolysis Potential during L-Asparaginase Therapy in Children with Acute Lymphoblastic LeukaemiaThrombosis and Haemostasis, 1990
- Involvement of von willebrand factor in thrombosis following asparaginase‐prednisone‐vincristine therapy for leukemiaAmerican Journal of Hematology, 1987
- Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia.Journal of Clinical Oncology, 1987
- Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasmaCancer, 1985
- Evidence for a rapid inhibitor to tissue plasminogen activator in plasmaThrombosis Research, 1983
- Factor-VIII-related antigen: measurement by enzyme immunoassay.BMJ, 1976
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957